Jonathan S. Abramowitz, PhD

Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

  • 3Articles
  • 5.5KReads1
  • 2005–2025Active
  • 7Collaborators

1 Read counts for articles published before 2020 may include some non-human traffic.

About

Jonathan S. Abramowitz, PhD, is affiliated with the Department of Psychology and Neuroscience at the University of North Carolina at Chapel Hill. His publications from 2005 to 2025 focus on obsessive-compulsive and related disorders, with particular attention to psychotherapy approaches and considerations for women. His work includes studies on exposure therapy for perinatal OCD, treatment strategies for obsessive-compulsive disorder, and clinical trial response definitions using the Yale-Brown Obsessive Compulsive Scale. He has frequently collaborated with co-authors such as David F. Tolin, Eric Hollander, Gretchen J. Diefenbach, Lorrin M. Koran, and Martha J. Falkenstein.

Publications

JCP
Exposure Therapy for Perinatal OCD: Navigating Evidence and Discomfort
Letter to the Editor

Exposure Therapy for Perinatal OCD: Navigating Evidence and Discomfort

November 17, 2025

Although patients and providers must be prepared for the temporary distress associated with exposure and response prevention, it remains the most effective nonpharmacologic treatment for OCD.
, ,
JCP
Academic Highlights

Obsessive-Compulsive Disorder: Strategies for Optimal Treatment

October 31, 2008

, , , et al
JCP
Original Research

Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale

December 15, 2005

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe